Literature DB >> 26414557

Myopic Shift during Hyperbaric Oxygenation Attributed to Lens Index Changes.

Knut Evanger1, Barbara K Pierscionek, Guro Vaagbø, Einar Thorsen, Olav H Haugen.   

Abstract

PURPOSE: To examine ocular lens parameters and structural changes to elucidate mechanisms underlying the myopic shift and cataract-related changes that occur in some patients during hyperbaric oxygen (HBO) therapy.
METHODS: Scheimpflug images (Nidek EAS-1000) of the crystalline lens, measurements of scattered light, objective refraction, keratometry, tonometry, and axial length of the eye were obtained after the first day of HBO therapy and repeated when patients had completed 19 days of the treatment.
RESULTS: Significant reduction in mean (± SD) optical density was found in the lens nucleus, -2.8 (± 4.3) units (p = 0.009) and -2.2 (± 4.1) units (p = 0.027) within circular and oval areas, respectively. Significant decrease in mean (± SD) backward scattered light was measured, -0.4 (± 0.8) units (p = 0.022). Mean (± SD) myopic shift was -0.58 (± 0.39) diopters (p < 0.001), whereas cortical optical density, forward scattered light, lenticular parameters, keratometry, tonometry, anterior chamber depth, and axial length of the eye appeared unchanged.
CONCLUSIONS: Transient myopic shift reported in patients during HBO therapy is attributed to changes in the refractive index of the lens. No changes in lens curvatures or thickness were found after treatment.

Entities:  

Mesh:

Year:  2015        PMID: 26414557     DOI: 10.1097/OPX.0000000000000705

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  2 in total

Review 1.  Hyperbaric Oxygen Therapy: Side Effects Defined and Quantified.

Authors:  Marvin Heyboer; Deepali Sharma; William Santiago; Norman McCulloch
Journal:  Adv Wound Care (New Rochelle)       Date:  2017-06-01       Impact factor: 4.730

2.  The myopic shift associated with hyperbaric oxygen administration is reduced when using a mask delivery system compared to a hood - a randomised controlled trial.

Authors:  Michael H Bennett; Cheng Fb Hui; Hooi G See; Kwan L Au-Yeung; Christopher Tan; Stephanie Watson
Journal:  Diving Hyperb Med       Date:  2019-12-20       Impact factor: 0.887

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.